tiprankstipranks
Trending News
More News >
AbbVie (DE:4AB)
XETRA:4AB
Germany Market

AbbVie (4AB) Technical Analysis

Compare
23 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
4Bullish
3Neutral
15Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
AbbVie’s (4AB) Moving Averages Convergence Divergence (MACD) indicator is -1.06, suggesting AbbVie is a Sell.
AbbVie’s (4AB) 20-Day exponential moving average is 161.91, while AbbVie’s (4AB) share price is €167.2, making it a Sell.
AbbVie’s (4AB) 50-Day exponential moving average is 164.53, while AbbVie’s (4AB) share price is €167.2, making it a Sell.

AbbVie (4AB) Pivot Points

Jul 11, 2025, 03:57 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
158.20
159.60
160.40
161.80
162.60
164.00
164.80
Fibonacci
159.60
160.44
160.96
161.80
162.64
163.16
164.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (4AB) Moving Averages

Jul 11, 2025, 03:57 PM
Period
Simple
Exponential
MA5
161.04Sell
161.14Sell
MA10
160.36Buy
161.19Sell
MA20
162.48Sell
161.91Sell
MA50
164.13Sell
164.53Sell
MA100
173.10Sell
167.81Sell
MA200
171.41Sell
168.41Sell
AbbVie’s (4AB) 10-Day exponential moving average is 161.19, while AbbVie’s (4AB) share price is €167.2, making it a Sell.
AbbVie’s (4AB) 100-Day exponential moving average is 167.81, while AbbVie’s (4AB) share price is €167.2, making it a Sell.
AbbVie’s (4AB) stock price is €167.2 and AbbVie’s (4AB) 50-day simple moving average is 164.13, creating a Sell signal.
AbbVie’s (4AB) stock price is €167.2 and AbbVie’s (4AB) 100-day simple moving average is 173.10, creating a Sell signal.
AbbVie’s (4AB) stock price is €167.2 and AbbVie’s (4AB) 200-day simple moving average is 171.41, creating a Sell signal.

AbbVie (4AB) Technical Indicators

Jul 11, 2025, 03:57 PM
Name
Value
Implied Action
RSI (14)
46.16
Neutral
STOCH (9,6)
82.50
Sell
STOCHRSI (14)
60.92
Neutral
MACD (12,26)
-1.06
Sell
ADX (14)
16.89
Buy
Williams %R
-39.58
Buy
CCI (14)
-63.05
Neutral
ATR (14)
2.83
-
Ultimate Oscillator
72.21
Buy
ROC
-2.07
Sell
AbbVie’s (4AB) Relative Strength Index (RSI) is 46.16, creating a Neutral signal.
AbbVie’s (4AB) Trend Strength Indicator (ADX) is 16.89, creating a Buy signal.
AbbVie’s (4AB) Commodity Channel Index (CCI) is -63.05, creating a Neutral signal.
AbbVie’s (4AB) Price Rate of Change (ROC) is -2.07, creating a Sell signal.

FAQ

Is 4AB a Buy, Hold, or Sell?
Based on 4AB’s technical indicators, 4AB is a Strong Sell.
    What is 4AB’s RSI (14)?
    4AB’s RSI (14) is 46.16, which suggests 4AB is a Neutral.
      What is 4AB’s MACD?
      4AB’s MACD is -1.06, which suggests 4AB is a Sell.
        What is 4AB’s 5-day moving average?
        4AB’s 5-day moving average is 161.04, which suggests 4AB is a Sell.
          What is 4AB’s 20-day moving average?
          4AB 20-day moving average is 162.48, which suggests 4AB is a Sell.
            What is 4AB’s 50-day moving average?
            4AB’s 50-day moving average is 164.13, which suggests 4AB is a Sell.
              What is 4AB’s 200-day moving average?
              4AB’s 200-day moving average is 171.41, which suggests 4AB is a Sell.
                What is 4AB’s Williams % R (14)?
                4AB’s Williams % R (14) is -39.58, which suggests 4AB is a Buy.
                  What is 4AB’s CCI (14)?
                  4AB’s CCI (14) is -63.05, which suggests 4AB is a Neutral.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis